Patent Oppositions in drug additives industry

Explore the competitive field of drug additives where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in drug additives technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the drug additives industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the drug additives industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Dosage Forms For Tyk2 InhibitorsBRISTOL MYERS SQUIBBSep 24, 2026SCORPIO
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 24, 2026MAIWALD PATENTANWALTS
Dosage Forms For Tyk2 InhibitorsBRISTOL MYERS SQUIBBSep 23, 2026SANDOZ
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 23, 2026PFIZER
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 10, 2026CAMULON
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 9, 2026LEPTHIEN
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 9, 2026LUMARA BIO ONCOLOGICS
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 9, 2026LUMARA BIO ONCOLOGICS
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 9, 2026LUMARA BIO ONCOLOGICS
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 4, 2026ABEL & IMRAY

To stay ahead in the competitive drug additives industry, companies are constantly innovating. Here are the top patents facing oppositions in the drug additives industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 26, 2025High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALS13
Jan 3, 2024Method For Producing Rna CompositionsCUREVAC MANUFACTURING8
Oct 25, 2023Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENT8
Jul 3, 2019Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS8
Feb 7, 2024Glp-1 Compositions And Uses ThereofNOVO NORDISK8
Jul 3, 2024Novel Pharmaceutical CompositionNOVARTIS7
Dec 30, 2020Controlled Release Pharmaceutical CompositionASTELLAS PHARMA7
Aug 2, 2023Gip/Glp1 Agonist CompositionsELI LILLY7
Nov 22, 2017Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection DevicesNOVO NORDISK7
Dec 24, 2025Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIO7